1.
Zhang J. FDX1 is a Potential Prognostic Biomarker Related to Cuproptosis and Immune Infiltration for Patients with Kidney Clear Cell Carcinoma. Annals KEMU [Internet]. 2024 Dec. 31 [cited 2025 Mar. 17];30(4):334-43. Available from: https://annalskemu.org/journal/index.php/annals/article/view/5531